3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
- 8 March 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (5) , 635-639
- https://doi.org/10.1016/s0960-894x(00)00721-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cellsCurrent Biology, 1994
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimidesJournal of Medicinal Chemistry, 1992
- A common denominator linking glycogen metabolism, nuclear oncogenes and developmentTrends in Biochemical Sciences, 1991
- Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.Journal of Clinical Investigation, 1990
- Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.Journal of Clinical Investigation, 1987
- Correlation between muscle glycogen synthase activity and in vivo insulin action in man.Journal of Clinical Investigation, 1984
- Separation and Characterisation of Glycogen Synthase Kinase 3,Glycogen Synthase Kinase 4 and Glycogen Synthase Kinase 5 from Rabbit Skeletal MuscleEuropean Journal of Biochemistry, 1982
- Carbamylmaleimides from the Malonamide-Diethyl Oxalate ReactionJournal of the American Chemical Society, 1958